RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Systematic literature review to identify cost estimates of liver disease in those with chronic hepatitis C virus (Hcv) in the United States
Mauskopf, J., Mitchell, S., Samuel, M., & Samp, JC. (2015). Systematic literature review to identify cost estimates of liver disease in those with chronic hepatitis C virus (Hcv) in the United States. Value in Health, 18(3), A236. https://doi.org/10.1016/j.jval.2015.03.1374
The objective of the review was to determine the most widely used estimates of United States (US) costs of different stages of liver disease in patients with hepatitis C virus (HCV) in cost-effectiveness analyses (CEA).
